Xiangcai Wang

760 total citations
29 papers, 463 citations indexed

About

Xiangcai Wang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangcai Wang has authored 29 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangcai Wang's work include Cancer Immunotherapy and Biomarkers (7 papers), Ubiquitin and proteasome pathways (4 papers) and Advanced Breast Cancer Therapies (4 papers). Xiangcai Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Ubiquitin and proteasome pathways (4 papers) and Advanced Breast Cancer Therapies (4 papers). Xiangcai Wang collaborates with scholars based in China, Ethiopia and Japan. Xiangcai Wang's co-authors include Xinqiang Wu, Longhuo Wu, Yuanbing Wu, Zhiping Liu, Liangmei He, Yanyang Wu, Zhao Zhai, Li Huang, Huabin Zhu and Zheng Guo and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

Xiangcai Wang

26 papers receiving 460 citations

Peers

Xiangcai Wang
I‐Che Chung Taiwan
Xinyu Shao China
Zhi Duan China
Sophie Van Welden Belgium
Hanju Hua China
Anne Benard Netherlands
Xingwei Xu China
Eleana Harmel-Laws United States
Haixiang Sun China
Hongdi Ma China
I‐Che Chung Taiwan
Xiangcai Wang
Citations per year, relative to Xiangcai Wang Xiangcai Wang (= 1×) peers I‐Che Chung

Countries citing papers authored by Xiangcai Wang

Since Specialization
Citations

This map shows the geographic impact of Xiangcai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangcai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangcai Wang more than expected).

Fields of papers citing papers by Xiangcai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangcai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangcai Wang. The network helps show where Xiangcai Wang may publish in the future.

Co-authorship network of co-authors of Xiangcai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangcai Wang. A scholar is included among the top collaborators of Xiangcai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangcai Wang. Xiangcai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Junyan, et al.. (2025). USP39: a key regulator in malignant tumor progression. Frontiers in Oncology. 15. 1556011–1556011. 1 indexed citations
2.
3.
Li, Junyan, et al.. (2025). USP38: an important regulatory factor in tumor malignant progression. Frontiers in Immunology. 16. 1612723–1612723.
4.
Xu, Rui, Yi Xie, Na Yang, et al.. (2025). Machine learning models for predicting metabolic dysfunction-associated steatotic liver disease prevalence using basic demographic and clinical characteristics. Journal of Translational Medicine. 23(1). 381–381. 4 indexed citations
5.
Liu, Jieqiong, et al.. (2025). Safety and Efficacy of KN046 in Combination with KN026 in Patients with Advanced HER2-Positive Breast Cancer: A Phase II Trial. Clinical Cancer Research. 31(12). 2379–2385. 4 indexed citations
6.
Li, An, Miao He, Xueming Xu, et al.. (2024). Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation. Cancer Cell International. 24(1). 2 indexed citations
7.
Luo, Xiaoning, et al.. (2023). Circ_0005615 promotes cervical cancer cell growth and metastasis by modulating the miR‐138‐5p/KDM2A axis. Journal of Biochemical and Molecular Toxicology. 37(9). e23410–e23410. 2 indexed citations
8.
Luo, Xiaoning, et al.. (2023). Circ‐DTL sponges miR‐758‐3p to accelerate cervical cancer malignant progression by regulating DCUN1D1 expression. Journal of Biochemical and Molecular Toxicology. 37(11). e23462–e23462. 1 indexed citations
9.
Li, Mingchun, Zhihua Liu, Xiangcai Wang, et al.. (2023). Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway. Thoracic Cancer. 14(14). 1223–1238. 5 indexed citations
10.
Zhou, Qing, Jun Zhao, Jianhua Chang, et al.. (2023). Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer. Cancer. 129(20). 3239–3251. 14 indexed citations
11.
Ye, Jianming, Xiaomei Xu, Wenting Zhou, et al.. (2022). OTO-Net: An Automated MRA Image Segmentation Network for Intracranial Aneurysms. Computational Intelligence and Neuroscience. 2022. 1–14. 3 indexed citations
12.
Zhang, Yuanyuan, Zhao Zhai, Xiangcai Wang, et al.. (2022). Lactate: The Mediator of Metabolism and Immunosuppression. Frontiers in Endocrinology. 13. 901495–901495. 67 indexed citations
13.
Liu, Rongrong, Weidong Liang, Xiangcai Wang, et al.. (2022). Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma. Frontiers in Immunology. 13. 819515–819515. 3 indexed citations
14.
15.
Wang, Xiangcai, et al.. (2022). MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients. Frontiers in Pharmacology. 13. 868203–868203. 5 indexed citations
16.
17.
Ye, Jianming, He Huang, Xiaomei Xu, et al.. (2021). Tumor Grade and Overall Survival Prediction of Gliomas Using Radiomics. Scientific Programming. 2021. 1–11. 4 indexed citations
18.
Wu, Yanyang, et al.. (2021). Peripheral blood inflammation indices are effective predictors of anastomotic leakage in elective esophageal surgery. Journal of Gastrointestinal Oncology. 12(6). 2675–2684. 6 indexed citations
19.
Wu, Xinqiang, Yuanbing Wu, Liangmei He, et al.. (2018). Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer. Journal of Cancer. 9(14). 2510–2517. 165 indexed citations
20.
Wu, Yuanbing, Xinqiang Wu, Longhuo Wu, Xiangcai Wang, & Zhiping Liu. (2017). The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy. Translational research. 190. 51–60. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I‐Che Chung Breakdown of academic impact, for papers by Xinyu Shao Breakdown of academic impact, for papers by Zhi Duan Breakdown of academic impact, for papers by Sophie Van Welden Breakdown of academic impact, for papers by Hanju Hua Breakdown of academic impact, for papers by Anne Benard Breakdown of academic impact, for papers by Xingwei Xu Breakdown of academic impact, for papers by Eleana Harmel-Laws Breakdown of academic impact, for papers by Haixiang Sun Breakdown of academic impact, for papers by Hongdi Ma
Rankless by CCL
2026